233 related articles for article (PubMed ID: 24850536)
1. Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge.
Mann AJ; Noulin N; Catchpole A; Stittelaar KJ; de Waal L; Veldhuis Kroeze EJ; Hinchcliffe M; Smith A; Montomoli E; Piccirella S; Osterhaus AD; Knight A; Oxford JS; Lapini G; Cox R; Lambkin-Williams R
PLoS One; 2014; 9(5):e93761. PubMed ID: 24850536
[TBL] [Abstract][Full Text] [Related]
2. A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge.
Smith D; Streatfield SJ; Acosta H; Ganesan S; Fattom A
Vaccine; 2019 Sep; 37(42):6162-6170. PubMed ID: 31495593
[TBL] [Abstract][Full Text] [Related]
3. A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.
Svindland SC; Pedersen GK; Pathirana RD; Bredholt G; Nøstbakken JK; Jul-Larsen Å; Guzmán CA; Montomoli E; Lapini G; Piccirella S; Jabbal-Gill I; Hinchcliffe M; Cox RJ
Influenza Other Respir Viruses; 2013 Nov; 7(6):1181-93. PubMed ID: 23170900
[TBL] [Abstract][Full Text] [Related]
4. Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine.
Baras B; Stittelaar KJ; Simon JH; Thoolen RJ; Mossman SP; Pistoor FH; van Amerongen G; Wettendorff MA; Hanon E; Osterhaus AD
PLoS One; 2008 Jan; 3(1):e1401. PubMed ID: 18167560
[TBL] [Abstract][Full Text] [Related]
5. Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
Sun X; Belser JA; Pulit-Penaloza JA; Creager HM; Guo Z; Jefferson SN; Liu F; York IA; Stevens J; Maines TR; Jernigan DB; Katz JM; Levine MZ; Tumpey TM
Virology; 2017 Aug; 508():164-169. PubMed ID: 28554058
[TBL] [Abstract][Full Text] [Related]
6. Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.
Major D; Chichester JA; Pathirana RD; Guilfoyle K; Shoji Y; Guzman CA; Yusibov V; Cox RJ
Hum Vaccin Immunother; 2015; 11(5):1235-43. PubMed ID: 25714901
[TBL] [Abstract][Full Text] [Related]
7. The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine.
Svindland SC; Jul-Larsen Å; Pathirana R; Andersen S; Madhun A; Montomoli E; Jabbal-Gill I; Cox RJ
Influenza Other Respir Viruses; 2012 Mar; 6(2):90-100. PubMed ID: 21749672
[TBL] [Abstract][Full Text] [Related]
8. A single immunization with CoVaccine HT-adjuvanted H5N1 influenza virus vaccine induces protective cellular and humoral immune responses in ferrets.
Bodewes R; Kreijtz JH; van Amerongen G; Geelhoed-Mieras MM; Verburgh RJ; Heldens JG; Bedwell J; van den Brand JM; Kuiken T; van Baalen CA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Virol; 2010 Aug; 84(16):7943-52. PubMed ID: 20519384
[TBL] [Abstract][Full Text] [Related]
9. Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets.
Layton RC; Petrovsky N; Gigliotti AP; Pollock Z; Knight J; Donart N; Pyles J; Harrod KS; Gao P; Koster F
Vaccine; 2011 Aug; 29(37):6242-51. PubMed ID: 21736913
[TBL] [Abstract][Full Text] [Related]
10. Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge.
Wang SH; Smith D; Cao Z; Chen J; Acosta H; Chichester JA; Yusibov V; Streatfield SJ; Fattom A; Baker JR
Vaccine; 2019 Mar; 37(12):1591-1600. PubMed ID: 30795941
[TBL] [Abstract][Full Text] [Related]
11. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
[TBL] [Abstract][Full Text] [Related]
12. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
[TBL] [Abstract][Full Text] [Related]
13. Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets.
Forrest HL; Khalenkov AM; Govorkova EA; Kim JK; Del Giudice G; Webster RG
Vaccine; 2009 Jun; 27(31):4187-95. PubMed ID: 19406182
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of an AS03A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs.
De Vleeschauwer AR; Baras B; Kyriakis CS; Jacob V; Planty C; Giannini SL; Mossman S; Van Reeth K
Vaccine; 2012 Aug; 30(37):5557-63. PubMed ID: 22727727
[TBL] [Abstract][Full Text] [Related]
15. Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.
Harada Y; Ninomiya-Mori A; Takahashi Y; Shirakura M; Kishida N; Kageyama T; Tada Y; Tashiro M; Odagiri T
Vaccine; 2011 Oct; 29(46):8330-7. PubMed ID: 21911027
[TBL] [Abstract][Full Text] [Related]
16. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
[TBL] [Abstract][Full Text] [Related]
17. Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model.
Pedersen G; Major D; Roseby S; Wood J; Madhun AS; Cox RJ
Influenza Other Respir Viruses; 2011 Nov; 5(6):426-37. PubMed ID: 21668670
[TBL] [Abstract][Full Text] [Related]
18. Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.
Mooney AJ; Li Z; Gabbard JD; He B; Tompkins SM
J Virol; 2013 Jan; 87(1):363-71. PubMed ID: 23077318
[TBL] [Abstract][Full Text] [Related]
19. Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets.
Baras B; Stittelaar KJ; Kuiken T; Jacob V; Bernhard R; Giannini S; de Waal L; van Amerongen G; Simon JH; Osterhaus AD; Hanon E; Mossman SP
Vaccine; 2011 Mar; 29(11):2092-9. PubMed ID: 21237275
[TBL] [Abstract][Full Text] [Related]
20. The safety and immunogenicity of a cell-derived adjuvanted H5N1 vaccine - A phase I randomized clinical trial.
Cheng A; Hsieh SM; Pan SC; Li YH; Hsieh EF; Lee HC; Lin TW; Lai KL; Chen C; Shi-Chung Chang S; Chang SC
J Microbiol Immunol Infect; 2019 Oct; 52(5):685-692. PubMed ID: 31255574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
